US Patent Issued to 2seventy bio on Feb. 10 for "Anti-BCMA car antibodies, conjugates, and methods of use" (Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,746, issued on Feb. 10, was assigned to 2seventy bio Inc. (Cambridge, Mass.).

"Anti-BCMA car antibodies, conjugates, and methods of use" was invented by Kevin Friedman (Melrose, Mass.) and Molly Reed Perkins (Milton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides improved methods for detecting anti-BCMA CAR expression on T cells. The invention generally provides antibodies and antigen binding fragments thereof, conjugates thereof, and methods of using the same to detect, determine, or measure CAR T cells and/or CAR expression on one or more T cells."

The patent was filed on Dec. 16, 2020, under Application No. 17/785,53...